- Home
- VRAX vs EVAX Comparison
VRAX vs EVAX Comparison
Compare VRAX & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- EVAX
- Stock Information
- Founded
- VRAX 2013
- EVAX 2008
- Country
- VRAX United Kingdom
- EVAX Denmark
- Employees
- VRAX N/A
- EVAX N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VRAX Health Care
- EVAX Health Care
- Exchange
- VRAX Nasdaq
- EVAX Nasdaq
- Market Cap
- VRAX 4.7M
- EVAX 15.1M
- IPO Year
- VRAX 2022
- EVAX 2021
- Fundamental
- Price
- VRAX $0.91
- EVAX $2.64
- Analyst Decision
- VRAX Strong Buy
- EVAX Strong Buy
- Analyst Count
- VRAX 1
- EVAX 2
- Target Price
- VRAX $3.00
- EVAX $10.00
- AVG Volume (30 Days)
- VRAX 46.8K
- EVAX 101.0K
- Earning Date
- VRAX 02-05-2025
- EVAX 08-13-2025
- Dividend Yield
- VRAX N/A
- EVAX N/A
- EPS Growth
- VRAX N/A
- EVAX N/A
- EPS
- VRAX N/A
- EVAX N/A
- Revenue
- VRAX $6,331.00
- EVAX $3,293,000.00
- Revenue This Year
- VRAX $217,274.83
- EVAX N/A
- Revenue Next Year
- VRAX N/A
- EVAX N/A
- P/E Ratio
- VRAX N/A
- EVAX N/A
- Revenue Growth
- VRAX N/A
- EVAX 2555.64
- 52 Week Low
- VRAX $0.74
- EVAX $1.20
- 52 Week High
- VRAX $9.00
- EVAX $17.75
- Technical
- Relative Strength Index (RSI)
- VRAX 50.78
- EVAX 55.56
- Support Level
- VRAX $0.84
- EVAX $2.26
- Resistance Level
- VRAX $0.99
- EVAX $2.60
- Average True Range (ATR)
- VRAX 0.07
- EVAX 0.21
- MACD
- VRAX 0.02
- EVAX -0.02
- Stochastic Oscillator
- VRAX 60.20
- EVAX 51.32
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.